ArticleFrontiers in medicine2024

Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.

Connor Prosty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.